Columbia Care Inc. CCHWF announced a collaboration Thursday with the pharma manufacturer IPS Specials.
The agreement will see Columbia Care’s BeneCeed CBD tablets imported into the United Kingdom for a clinical study.
Why It Matters
The agreement is the first step in Columbia Care's efforts to hold global clinical trials using its cannabis, the company said.
BeneCeed will become the first approved cannabinoid investigational medicinal product imported from the U.S. by the U.K.’s Medicines and Healthcare products Regulatory Agency.
BeneCeed would be used in an examination of a late-stage Phase 2b trial.
Rosemary Mazanet, Columbia Care’s chief scientific officer, touched on the importance of the news in a statement.
“I am proud that we are now raising the bar once more with our funding and independent research partners as we move closer to reaching this momentous milestone for our company.”
IPS Specials has nearly two decades of experience facilitating the import of investigational medicinal products, Mazanet said. Columbia Care is also working with Grow Biotech, "a specialist in navigating challenging regulatory frameworks across the world," to coordinate the effort, she said.
Columbia Care's stock was trading down 1.27% at $4.75 at the time of publication Thursday.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!